Antagonists of the arousal-promoting system such as antidepressants, neuroleptics or antihistaminergic compounds with histaminic or 5HT2 antagonism have been used for decades in the treatment of insomnia (Sateia et al., 2017; Riemann et al., 2023a). This evidence concerns the gene HTR2A and insomnia.